Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily L Heil

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
Antiviral Therapy|April 29, 2020
The effect of veno-arterial extracorporeal oxygenation and nasogastric tube administration on the pharmacokinetic profile of abacavir, lamivudine and dolutegravir: a case reportAlison L Blackman, Emily L Heil, Aaron S Devanathan, et al.
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021
Are Fluoroquinolones Appropriate for the Treatment of Extended-Spectrum β-Lactamase-Producing Gram-Negative Bacilli?Emily S Wiener, Emily L Heil, Lauren M Hynicka, et al.
Pharmacotherapy|October 24, 2021
The role of tazobactam-based combinations for the management of infections due to extended-spectrum β-lactamase-producing Enterobacterales: Insights from the Society of Infectious Diseases PharmacistsMarguerite L Monogue, Emily L Heil, Samuel L Aitken, et al.
Open Forum Infectious Diseases|September 5, 2025
Navigating the Muddled Middle: A Case-Based Exploration of Oral β-Lactams for Systemic Gram-Negative InfectionsJennifer Shif, Hawi Tasissa, Conan MacDougall, et al.
Journal of Clinical Pharmacy and Therapeutics|July 14, 2018
Treatment strategies for persistent methicillin-resistant Staphylococcus aureus bacteraemiaPaul O Lewis, Emily L Heil, Kelly L Covert, et al.
Open Forum Infectious Diseases|July 15, 2021
<i>Streptococcus pyogenes</i> Infective Endocarditis-Association With Injection Drug Use: Case Series and Review of the LiteratureMelanie T Rebechi, Emily L Heil, Paul M Luethy, et al.
Infection Control and Hospital Epidemiology|April 14, 2016
The Essential Role of Pharmacists in Antimicrobial StewardshipEmily L Heil, Joseph L Kuti, David T Bearden, et al.
Expert Opinion on Pharmacotherapy|February 20, 2016
Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteriaRyan G D'Angelo, Jennifer K Johnson, Jacqueline T Bork, et al.
Pharmacotherapy|January 6, 2015
Treatment of multidrug-resistant pseudomonas aeruginosa using extended-infusion antimicrobial regimensEmily L Heil, Ashleigh V Lowery, Kerri A Thom, et al.
Infection Control and Hospital Epidemiology|October 26, 2017
Peer Comparison of Anti-MRSA Agent Prescription in the Inpatient SettingJacqueline T Bork, Daniel J Morgan, Emily L Heil, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Antiviral Therapy|April 29, 2020
The effect of veno-arterial extracorporeal oxygenation and nasogastric tube administration on the pharmacokinetic profile of abacavir, lamivudine and dolutegravir: a case reportAlison L Blackman, Emily L Heil, Aaron S Devanathan, et al.
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021
Are Fluoroquinolones Appropriate for the Treatment of Extended-Spectrum β-Lactamase-Producing Gram-Negative Bacilli?Emily S Wiener, Emily L Heil, Lauren M Hynicka, et al.
Pharmacotherapy|October 24, 2021
The role of tazobactam-based combinations for the management of infections due to extended-spectrum β-lactamase-producing Enterobacterales: Insights from the Society of Infectious Diseases PharmacistsMarguerite L Monogue, Emily L Heil, Samuel L Aitken, et al.
Open Forum Infectious Diseases|September 5, 2025
Navigating the Muddled Middle: A Case-Based Exploration of Oral β-Lactams for Systemic Gram-Negative InfectionsJennifer Shif, Hawi Tasissa, Conan MacDougall, et al.
Journal of Clinical Pharmacy and Therapeutics|July 14, 2018
Treatment strategies for persistent methicillin-resistant Staphylococcus aureus bacteraemiaPaul O Lewis, Emily L Heil, Kelly L Covert, et al.
Open Forum Infectious Diseases|July 15, 2021
<i>Streptococcus pyogenes</i> Infective Endocarditis-Association With Injection Drug Use: Case Series and Review of the LiteratureMelanie T Rebechi, Emily L Heil, Paul M Luethy, et al.
Infection Control and Hospital Epidemiology|April 14, 2016
The Essential Role of Pharmacists in Antimicrobial StewardshipEmily L Heil, Joseph L Kuti, David T Bearden, et al.
Expert Opinion on Pharmacotherapy|February 20, 2016
Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteriaRyan G D'Angelo, Jennifer K Johnson, Jacqueline T Bork, et al.
Pharmacotherapy|January 6, 2015
Treatment of multidrug-resistant pseudomonas aeruginosa using extended-infusion antimicrobial regimensEmily L Heil, Ashleigh V Lowery, Kerri A Thom, et al.
Infection Control and Hospital Epidemiology|October 26, 2017
Peer Comparison of Anti-MRSA Agent Prescription in the Inpatient SettingJacqueline T Bork, Daniel J Morgan, Emily L Heil, et al.
Pageof 12